(Q35808632)

10 August 2017

1 reference

title

Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis (English)

1 reference

10 August 2017

1 reference

6

Winfried März

1 reference

10 August 2017

3

Stefan Pilz

1 reference

10 August 2017

5

Wilfried Renner

1 reference

10 August 2017

Harald Mangge

1

1 reference

PubMed ID

15202781

10 August 2017

Holger Hubmann

series ordinal

2

1 reference

PubMed ID

15202781

10 August 2017

Konrad Schauenstein

series ordinal

4

1 reference

10 August 2017

1 May 2004

1 reference

Clinical Chemistry and Laboratory Medicine

10 August 2017

1 reference

10 August 2017

42

1 reference

10 August 2017

5

1 reference

10 August 2017

467-474

1 reference

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

10 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Human monocyte chemoattractant protein-1 (MCP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Autoimmunity, oxidized LDL and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Tyrosine kinase activity is involved in the protein kinase C induced expression of interleukin-1 beta gene in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Shear stress induction of the tissue factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Genetic manipulation of vascular adhesion molecules in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Atherosclerosis as an autoimmune disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Increased plasma concentrations of interleukin-18 in acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Expression of functional CD40 by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Autoreactive antibody repertoire is perturbed in atherosclerotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Vaccination against atherosclerosis: science or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Role of heat shock proteins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Atherosclerosis and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Immunomodulation for treatment and prevention of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Arterial inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Expansion of unusual CD4+ T cells in severe rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Altered cholesterol trafficking in herpesvirus-infected arterial cells. Evidence for viral protein kinase-mediated cholesterol accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Herpesviruses and thrombosis: activation of coagulation on the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.081

21 January 2018

Identifiers

DOI

10.1515/CCLM.2004.081

1 reference

10 August 2017

1 reference

PubMed ID

15202781